Shopping Cart
Remove All
Your shopping cart is currently empty
O-2050 is a high-affinity cannabinoid CB1 receptor antagonist with a Ki of 2.5 nM and inhibits the cannabinoid CB2 receptor with a Ki of 0.2 nM. O-2050 decreased food intake and stimulated locomotion in mice [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $2,140 | 8-10 weeks | 8-10 weeks | |
| 50 mg | $2,785 | 8-10 weeks | 8-10 weeks | |
| 100 mg | $3,520 | 8-10 weeks | 8-10 weeks |
| Description | O-2050 is a high-affinity cannabinoid CB1 receptor antagonist with a Ki of 2.5 nM and inhibits the cannabinoid CB2 receptor with a Ki of 0.2 nM. O-2050 decreased food intake and stimulated locomotion in mice [1]. |
| Targets&IC50 | CB2:0.2 nM (Ki), CB1:2.5 nM (Ki) |
| In vivo | O-2050, administered intraperitoneally at doses of 1, 3, 10, and 30 mg/kg with a 30-minute pretreatment, significantly reduces food intake in mice in a dose-dependent manner. Notably, doses of 10 and 30 mg/kg of O-2050 also significantly enhance locomotor activity [1]. |
| Molecular Weight | 417.56 |
| Formula | C23H31NO4S |
| Cas No. | 1883545-42-3 |
| Relative Density. | 1.173 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: <41.76 mg/mL, Sonication is recommended. Ethanol: <41.76 mg/mL, Sonication is recommended. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.